Celldex cuts workforce by 20% after cancer drug trial failure

12:07 EDT 26 Apr 2018 | Pharmaceutical Technology

Targeted therapeutics company Celldex has announced it is reducing its employee numbers by 20% after a cancer drug failed to...
Read More...

The post Celldex cuts workforce by 20% after cancer drug trial failure appeared first on Pharmaceutical Technology.

Original Article: Celldex cuts workforce by 20% after cancer drug trial failure

More From BioPortfolio on "Celldex cuts workforce by 20% after cancer drug trial failure"